| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XERS | Common Stock | Options Exercise | $429,044 | +215,600 | +40% | $1.99 | 751,412 | 18 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XERS | Stock Option (Right to Buy) | Options Exercise | $0 | -215,600 | -100% | $0.000000* | 0 | 18 Mar 2024 | Common Stock | 215,600 | $1.99 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The options to purchase shares of Xeris Biopharma Holdings Inc. common stock fully vested on October 5, 2021. |